WORLD NEWS SUPERFAST
Coronavirus Vaccine News - According to information received by World News Superfast, Russian vaccine of Coronavirus is being prepared in Sputnik India. Russian Embassy issued a statement citing Kirill Dimitriv, CEO of the Russian Direct Investment Fund (RDF). Said - By the end of 2021, next year of Sputnik, 30 million doses of this vaccine will be prepared. All these will be prepared in India.
Vaccination started in Saudi
According to information received by World News Superfast, since Thursday, Saudi Arabia has started a campaign to install Corona vaccine. The first vaccine was applied to the country's health minister, Dr. Taufiq Al Rabih. The Ministry of Health gave this information on social media. So far, three lakh 60 thousand 516 patients have been found in the country. Of these, 6 thousand 91 have lost their lives.
After getting the vaccine, Dr. Taufiq said that this is the beginning of the end of a big problem. He announced the launch of the country's largest vaccination program. Till now the US, Canada, UK, Bahrain and Russia have started this drive.
A total of 12 thousand 196 cases were reported in Colombia on Thursday.
According to information received by World News Superfast, 13 thousand 55 cases were reported in a single day in August. A total of 14 lakh 68 thousand 795 cases have been reported here so far. During this period, 39 thousand 787 people have also died. President Evan Duke held a meeting with Health Ministry officials on Thursday. In a statement issued after this, people were warned. Said- be restrained during the festive season, because the infection is spreading rather than decreasing.
The Colombian government says it is difficult to start vaccination before January 2021. However, the government has made all preparations for this. Apart from South American countries, Brazil is the most affected.
Relief to biden
According to information received by World News Superfast, US President Elect Joe Biden's test report came negative on Thursday night. His White House adviser Cedric Richmond was found positive on Thursday. He had been in constant contact with Biden for several days. Biden spokeswoman said - Corona test of President Elect was done. His test report has come negative. His adviser, Mr. Richmond, was found positive.
President Elect will get the vaccination done publicly next week. On the other hand, the Health Ministry has made it clear that vaccine doses sent to the states will go up significantly from Monday.
India can ask for local trials before approving Pfizer's vaccine
According to information received by World News Superfast, Pfizer's Corona vaccine has so far received emergency approval in more than 5 countries including the US, UK. The process of vaccinating healthworkers and high-groups has also started in many countries. But emergency approval will not be easy for him in India. The Subject Expert Committee of the Drug Regulator recommending emergency approval may ask him for trials in India.
According to a Mint report, the trial data that Pfizer has presented
According to information received by World News Superfast, trial data related to Volunteers associated with Indian Ethnicity is not sufficient. A researcher associated with the regulatory process of the vaccine said that for any vaccine, you have to provide data on trials on the local population. If Pfizer's Global Trials had some data on the trials on the Indian population, it could have been exempted from the imperative of clinical trials. But it seems that his data is not enough. The possibility of waiver of clinical trials seems quite low at this time.
Earlier, Dr. Gagandeep Kang, the country's top vaccine scientist and professor of Christian Medical College, had also expressed the possibility that India's drug regulator could ask foreign vaccine for trials in India if they applied for emergency approval. May be asked to do this trial on 100 Indians. All this is decided on the data of trials conducted worldwide.
What is the need for local trials?
If the Drug Controller General of India VG Somani and the Subject Expert Committee approved the Pfizer vaccine, it would be a completely new technology here. Actually, Pfizer's vaccine is made up of messenger-RNA or mRNA technology, trials of which have not happened in India. In such a situation, giving emergency approval based on only global trial data can be risky.
Pfizer's global phase-3 clinical trial was attended by 37,000 volunteers. Of this only 4.3% people were of Asian descent. Even though the overall efficacy of the vaccine was 95%, its success rate was 74.4% for people of Asian descent. 50% is considered as a cut-off for the corona vaccine, so 74.4% can also be considered a good figure. But it is also clear that the sample size was not enough.
What about the rest of the vaccine?
According to information received by World News Superfast, at this time, along with Pfizer, Serum Institute of India (SII) and Bharat Biotech have also applied for emergency approval for their vaccines. SII has sought approval for the Kovyshield vaccine developed by Oxford and AstraZeneca, with phase-3 trials currently running across the country. Similarly, phase-3 trials of the first indigenous corona vaccine-covaxin of Bharat Biotech are also being run in many hospitals in the country.
Pfizer vaccine will be cheaper for Indians
According to information received by World News Superfast, Pfizer has stated that the price of its vaccine BNT162b2 will be priced in such a way that people have to spend little or no. In this, he is also willing to work with the Government of India. In the US, the company has fixed the price of one dose of its vaccine at $ 19.5 (Rs 1,440). But in India this rate may be reduced.
According to information received by World News Superfast, another problem with Pfizer's vaccine is to keep it at -70 ° C, for which the company has made special temperature-controlled thermal shippers, which can be used as a temporary storage unit. is. Compared to Pfizer, SII's vaccine - Kovyshield is going to be around $ 3 dollars i.e. about 221 rupees. Similarly, the Russian vaccine Sputnik V will also be cheaper than Pfizer and one of its doses will cost $ 10 dollars (Rs 735). The vaccines of indigenous vaccine companies Bharat Biotech and Zydus Cadila are priced between $ 3- $ 6, ie between 220 to 500 rupees.
No comments:
Post a Comment